ETrade Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$607K Sell
4,104
-958
-19% -$148K 0.01% 511
2020
Q2
$831K Sell
5,062
-12,226
-71% -$1.88M 0.02% 408
2020
Q1
$2.4M Buy
17,288
+6,078
+54% +$835K 0.06% 164
2019
Q4
$1.47M Sell
11,210
-1,178
-10% -$137K 0.03% 266
2019
Q3
$1.39M Sell
12,388
-13,950
-53% -$1.55M 0.03% 271
2019
Q2
$2.92M Buy
26,338
+1,710
+7% +$201K 0.08% 154
2019
Q1
$3.2M Sell
24,628
-11,245
-31% -$1.37M 0.09% 129
2018
Q4
$4.15M Buy
35,873
+168
+0.5% +$18.8K 0.14% 80
2018
Q3
$3.83M Sell
35,705
-4,481
-11% -$448K 0.11% 103
2018
Q2
$3.43M Buy
40,186
+18,653
+87% +$1.53M 0.11% 108
2018
Q1
$1.67M Sell
21,533
-205
-0.9% -$16.5K 0.05% 210
2017
Q4
$1.84M Buy
21,738
+1,236
+6% +$105K 0.06% 194
2017
Q3
$1.75M Buy
20,502
+1,754
+9% +$144K 0.06% 181
2017
Q2
$1.54M Buy
18,748
+2,138
+13% +$174K 0.06% 191
2017
Q1
$1.4M Buy
16,610
+208
+1% +$16.7K 0.06% 190
2016
Q4
$1.21M Buy
16,402
+3,498
+27% +$261K 0.06% 189
2016
Q3
$1.04M Buy
12,904
+3,531
+38% +$283K 0.05% 208
2016
Q2
$738K Buy
9,373
+1,443
+18% +$109K 0.04% 278
2016
Q1
$571K Sell
7,930
-317
-4% -$24K 0.03% 312
2015
Q4
$694K Buy
+8,247
New +$684K 0.04% 264
2014
Q2
Sell
-1,274
Closed -$75K 585
2014
Q1
$75K Buy
1,274
+527
+71% +$29.4K 0.01% 527
2013
Q4
$38K Sell
747
-130
-15% -$6.51K ﹤0.01% 498
2013
Q3
$44K Buy
877
+325
+59% +$17K ﹤0.01% 447
2013
Q2
$27K Buy
+552
New +$30K ﹤0.01% 455

Other funds holding LLY

ETrade Capital Management's LLY Position: Q3 2020 in Review

ETrade Capital Management reduced its Eli Lilly (LLY) stake by 19% in Q3 2020, selling an estimated $148K and leaving 4,104 shares worth $607K. The position accounts for 0.01% of the portfolio, ranked #511.

ETrade Capital Management first reported a position in LLY in Q2 2013 and has held it in 24 quarters since. The position peaked at $4.15M in Q4 2018. 1,774 funds tracked by Wall St. Rank hold LLY as of Q3 2020.

  • ETrade Capital Management held 4,104 shares of Eli Lilly worth $607K as of Q3 2020.
  • ETrade Capital Management sold 958 Eli Lilly shares in Q3 2020, an estimated $148K.
  • Eli Lilly made up 0.01% of ETrade Capital Management's portfolio in Q3 2020, its #511 holding.
  • ETrade Capital Management first reported a position in Eli Lilly in Q2 2013 and has held it in 24 quarters since.
  • ETrade Capital Management's Eli Lilly position peaked at $4.15M in Q4 2018.
  • 1,774 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2020.

Based on ETrade Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.